HAMPTON, Va., July 11, 2011 /PRNewswire-USNewswire/ — Patient
Advocate Foundation (PAF), a national non-profit organization that
seeks to safeguard patients through effective mediation assuring
access to care, maintenance of employment and preservation of their
financial stability relative to their diagnosis of life-threatening
or debilitating diseases, is pleased to announce improvements to
its Co-Pay Relief (CPR) Program beginning on August 1, 2011 that
will allow more patients to be served through a new operational
model and will provide enhanced service to both providers and
patients through new technology tools.
PAF’s Co-Pay Relief Program provides direct financial support
for pharmaceutical co-payments to insured patients, including
Medicare Part D beneficiaries, who financially and medically
qualify and are being treated for breast, lung, prostate, kidney,
colon, non squamous non small cell lung and non muscle invasive
bladder cancers, malignant brain tumor, cutaneous t-cell
lymphoma sarcoma, multiple myeloma, myelodysplastic syndrome
(and other pre-leukemia diseases), osteoporosis, pain, hepatitis C,
rheumatoid arthritis, selected autoimmune disorders, CIA/CIN and
patients undergoing hormone suppression therapy. Since the
program’s inception in April 2004, CPR distributed more than $120
million in assistance to more than 46,000 patients who were unable
to afford their pharmaceutical co-payments.
CPR donations will now be released in total into each disease
silo immediately upon receipt, rather than dividing contributions
across a twelve month period. CPR will accept all qualified new and
renewal applications on a first come, first serve basis with no
limit imposed on the number of approvals issued monthly. CPR will
also accept and process all expenditures on a first come, first
serve basis until the available funds in the entire silo are
exhausted. Eligible expenditures may be submitted by patients,
providers and/or pharmacist
‘/>”/>